Thermo Fisher's $9.4 Billion Move into Digital Health
Thermo Fisher is set to acquire data management firm Clario for up to $9.4 billion, enhancing its position in digital health. The move is accompanied by Centene's upbeat forecast after a surprise profit, rising health issues in younger adults, rising sales for Straumann, and CDC's study on offshore wind farms.
Thermo Fisher has announced its plan to acquire Clario, a private data management company, in a deal valued at up to $9.4 billion. This acquisition will bolster Thermo Fisher's capabilities in digital health and clinical research. The transaction details include an upfront payment and performance-based earn-out payments.
Meanwhile, Centene has raised its annual earnings outlook following a surprising profit in the third quarter, which sent its shares soaring. Despite a significant goodwill impairment, the company is optimistic about its financial trajectory.
In the broader health sector, a marked increase in severe colon disorder among young adults has been observed, while Straumann reported robust sales growth in dental implants. Additionally, the CDC, directed by U.S. Health Secretary Robert F. Kennedy Jr., is investigating offshore wind farms' health impacts.
Google News